EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Critical Contribution of Various Signaling Pathways in the Development of Drug Resistance in Colorectal Cancer: An Update

Mehran Molavand iD, Maryam Majidinia iD, Bahman Yousefi iD

IUBMB Life · 2025

DOI: 10.1002/iub.70074 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift IUBMB Life, 2025. Verfasst von Mehran Molavand und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Signal Transduction, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 358 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the second leading cause of cancer‐related deaths worldwide, with drug resistance being a major challenge in limiting the available treatment options. This review focuses on the signaling pathways (Hedgehog, Hippo, Notch, Wnt/β‐catenin, PI3K/Akt, and MAPK/ERK pathways) that are implicated in the development of drug resistance mechanisms in CRC, such as DNA repair systems, tumor microenvironments, autophagy, metabolic reprogramming, evasion of apoptosis, and efflux pumps. Furthermore, recent advancements in targeted and combinatorial diagnostic‐therapeutic approaches are highlighted. This review delineates the significance of signaling cascades and their clinical relevance, offering novel perspectives on the formulation of therapeutic strategies to mitigate drug resistance. In light of the increasing prevalence of drug‐resistant CRC and the lack of effective solutions, it addresses the persistent demand for improved therapeutic modalities and provides a comprehensive framework for forthcoming research in this domain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDrug Resistance, NeoplasmSignal TransductionAntineoplastic AgentsHumansTumor MicroenvironmentAnimalsAutophagy

Stichwörter der Autor:innen

MAPK/ERKPI3K/AktWnt/β‐catenincolorectal cancerdrug resistancehedgehoghipponotchsignaling pathways

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Science, Tabriz, Iran.
  • Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.

ORCID-Profile: Mehran Molavand, Maryam Majidinia, Bahman Yousefi

Zitieren

APA

Molavand, M., Majidinia, M., & Yousefi, B. (2025). Critical Contribution of Various Signaling Pathways in the Development of Drug Resistance in Colorectal Cancer: An Update. IUBMB Life. https://doi.org/10.1002/iub.70074

Vancouver

Molavand M, Majidinia M, Yousefi B. Critical Contribution of Various Signaling Pathways in the Development of Drug Resistance in Colorectal Cancer: An Update. IUBMB Life. 2025. doi:10.1002/iub.70074

BibTeX
@article{Molavand2025,
  author = {Molavand, Mehran and Majidinia, Maryam and Yousefi, Bahman},
  title = {Critical Contribution of Various Signaling Pathways in the Development of Drug Resistance in Colorectal Cancer: An Update},
  journal = {IUBMB Life},
  year = {2025},
  doi = {10.1002/iub.70074}
}
Kostenlos starten →